GF53100UG
MilliporeSigma™ anti-Tissue Plasminogen Activator Clone: GMA-043,
Manufacturer: MilliporeSigma™
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | GF53100UG-Each-of-1 | In Stock | ₹ 37,706.63 |
GF53100UG - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,706.63
GST (18%): ₹ 6,787.193
Total Price: ₹ 44,493.823
Antigen
Tissue Plasminogen Activator
Classification
Monoclonal
Conjugate
Unconjugated
Host Species
Mouse
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
ELISA, Immunoblot, Immunoblot
Clone
GMA-043
Formulation
In 150mM NaCl, 10mM sodium phosphate, 1% mannitol, pH 7.4.
Immunogen
purified human tissue plasminogen activator (tPA)
Regulatory Status
RUO
Test Specificity
Recognizes the ∽60kDa tPA protein.
Content And Storage
−20°C
Isotype
IgG1
Related Products
Description
- Specifically detects Tissue Plasminogen Activator Clone: GMA-043 in Human samples, and it is validated for ELISA, Immuno Blotting Epidemiological studies have demonstrated that levels of plasma fibrinogen, von Willebrand factor (vWf), plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (tPA) are associated with the incidence of vascular disease
- Von Willebrand factor (vWF) is a large, multimeric glycoprotein mediating platelet adhesion at sites of endothelial damage
- The process of acute release of tissue-type plasminogen activator (tPA) is important in locally speeding up fibrinolysis
- Acutely released tPA and constitutively secreted tPA were liberated from different pathways in human umbilical vein endothelial cells
- Plasma levels of tissue plasminogen activator to plasminogen activator/ inhibitor-1 complex, in addition to von Willebrand factor, are significant risk markers for recurrent myocardial infarction.